Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Promising model for rare diseases in Bespoke Gene Therapy Consortium
The definition of a rare disease in the U.S. is under 200,000 patients. The 10 per cent of Americans living with a rare disease is equivalent to 30 million people. Put another way, that is close to the entire population of Canada (at 39 million). There are 7,000 – 10,000 rare diseases in the U.S. […]
Right Turn: Surviving the cure
Courtney Horvath, PhD, is a board certified toxicologist who knows firsthand about toxicity in pediatric oncology treatments. Her son, Colby, was diagnosed with lymphoma at the age of eight, in March 2020, and she has since become an advocate for better cancer treatments for children. At the end of this post I have shared a […]
Right Turn: The awe-inspiring Tak Mak
Toronto, Canada’s Tak Mak, OC, OOnt, FRS, FRSC, has won the prestigious Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research, valued at US$100,000. Dr. Mak, who has his lab at the Princess Margaret Cancer Centre (PMCC), is widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology […]
Right Turn: Inspiring Toronto family fundraises treatment for rare disease
If you’ve watched the 1992 movie Lorenzo’s Oil, based on the true story of parents searching for a treatment for their son’s rare neurological disease, adrenoleukodystrophy (ALD), then the real-life story of the Pirovolakis family might feel familiar. The Pirovolakis family lives in Toronto, Canada. In 2017 their son Michael was born and later diagnosed […]
Government funding for regenerative medicine is making a difference
The Networks of Centres of Excellence (NCE) program has been on my mind lately. Yes it’s true, although it may seem odd to admit. The Government of Canada’s innovative program, launched in 1989, was intended to “mobilize Canada’s best research, development and entrepreneurial talent, and focus it on specific issues and strategic areas.” Canada is […]